| http://www.w3.org/ns/prov#value | - ISIS 133726 inhibited the expression of ICAM-1, IL-8 and MIP2?? in response to IL-1 stimulation, and therefore is a candidate agent for the treatment of conditions in which inhibition or reduction of the inflammatory response is desirable, for example, in conditions such as rheumatoid arthritis, asthma and inflammatory bowel diseases.
|
